Literature DB >> 2451245

Induction and properties of syngeneic murine anti-immunoglobulin D.

S Haba1, G J Thorbecke, A Nisonoff.   

Abstract

High titers of autoantibodies directed to isotypic determinants of IgD were produced by inoculation of syngeneic monoclonal IgD, conjugated covalently to keyhole limpet hemocyanin, into adult or neonatal inbred mice. Anti-idiotypic antibodies were induced at the same time. The average affinity of the mouse antibodies (Ka approximately equal to 10(7) M-1) is similar to that of rabbit anti-IgD and of syngeneic anti-IgE induced by the same procedure. Results indicate that B cells of the mice are not tolerant to serum IgD and that tolerance is maintained at the level of T cells. Direct interaction of the syngeneic anti-IgD with cell-surface IgD was minimal, and there was no convincing evidence that cell-surface IgD was down-regulated in the anti-IgD-producing mice. Further studies, preferably employing monoclonal anti-IgD, are required to determine whether epitopes on cell-surface IgD can be recognized by syngeneic anti-IgD. The ability to generate in vivo high titers of anti-IgD should facilitate the production of such monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451245      PMCID: PMC279977          DOI: 10.1073/pnas.85.7.2293

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Suppression of specific IgM, IgA and IgG responses in mice treated with anti-delta from birth.

Authors:  P M Wathen; D D Manning
Journal:  Eur J Immunol       Date:  1986-08       Impact factor: 5.532

2.  Induction of high titers of anti-IgE by immunization of inbred mice with syngeneic IgE.

Authors:  S Haba; A Nisonoff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

3.  Physiology of IgD. III. Effect of treatment with anti-IgD from birth on the magnitude and isotype distribution of the immune response in the spleen.

Authors:  B Xue; T Hirano; B Pernis; Z Ovary; G J Thorbecke
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

4.  B-cell function in mice treated with anti-IgD from birth.

Authors:  E S Metcalf; J J Mond; I Scher; M A LaVeck; F D Finkelman
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  Circulating autoantibodies to IgD in rheumatic diseases.

Authors:  R M Pope; R Keightley; S McDuffy
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

6.  Physiology of Igd. II. Lack of humoral immune responsiveness in lymph nodes of mice treated with anti-IgD from birth.

Authors:  Y Baine; Y W Chen; E B Jacobson; B Pernis; G W Siskind; G J Thorbecke
Journal:  Eur J Immunol       Date:  1982-10       Impact factor: 5.532

7.  Cell surface phenotype of lymphoid cells from normal mice and mice treated with monoclonal anti-IgD from birth.

Authors:  R R Skelly; Y Baine; A Ahmed; B Xue; G J Thorbecke
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations.

Authors:  R F Coico; B Xue; D Wallace; G W Siskind; G J Thorbecke
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

9.  Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies.

Authors:  E B Jacobson; Y Baine; Y W Chen; T Flotte; M J O'Neil; B Pernis; G W Siskind; G J Thorbecke; P Tonda
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

10.  Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas.

Authors:  B Xue; R Coico; D Wallace; G W Siskind; B Pernis; G J Thorbecke
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

View more
  1 in total

1.  Immunological responsiveness of neonatal A/J mice to isotypic determinants of syngeneic IgE.

Authors:  S Haba; A Nisonoff
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.